the year 2017 in charts

2017. Pharma Marketing Network. All rights reserved.

The Year 2017 in Charts

TM


FDA Drug Approvals See Best Year Since 1996

The FDA hit 46 approvals for 2017. That’s the most in at least a decade.

The tally includes NMEs (New Molecular Entities –traditional drugs) and BLAs (Biologic License Applications – these are manufactured biologics, which do not include vaccines).

http://sco.lt/61T6Jd

http://sco.lt/61T6Jd


Orphan Drug Designations by FDA


7 Out of 10 Top Selling Drugs Have Orphan StatusAn investigation by Kaiser Health News that NPR published and aired in January found that many drugs with orphan status weren’t entirely new when approved. Of about 450 drugs that have won orphan approval since 1983, more than 70 were drugs first greenlighted by the FDA for mass-market uses. Those include the cholesterol blockbuster Crestor, Abilify for psychiatric disorders, and the rheumatoid arthritis drug Humira, the world’s best-selling drug.

http://sco.lt/9B2uiv

http://sco.lt/9B2uiv


Is FDA Too Slow to Approve New Drugs?

President Trump claimed that the U.S. Food and Drug Administration’s approval process for medical products is “slow and burdensome” and “keeps too many advances … from reaching those in need.”

Do the data in this and the previous slide dispute that?

http://sco.lt/8cp2PZ

http://sco.lt/8cp2PZ


Meanwhile FDA Letters Are a Rarity


Drug Safety Events Common after FDA Approval

http://sco.lt/94NCyH

http://sco.lt/94NCyH


US Drug Spend Growth Slows in 2016

The U.S. health system's spending on prescription drugs grew by 5.8% to $450 billion in 2016, the slowest growth rate over the last two years, according to an annual report released Thursday by the QuintilesIMS Institute. U.S. drug spend jumped 12% in 2015 to $425 billion, compared to 2014.

http://sco.lt/5D91of

http://sco.lt/5D91of


Big Pharma's Effective Tax Rate is Lower Than Yours!

http://sco.lt/6aaB6X

http://sco.lt/6aaB6X


Want an ROI of 2.7? Overcharge Medicaid!For years, Mylan classified EpiPen in a way that forced Medicaid to overpay for the product, according to the Centers for Medicare and Medicaid Services. The company may have over-charged taxpayers as much as $1.27 billion over 10 years, the Department of Health and Human Services’s watchdog organization said in May, 2017.

http://sco.lt/9CtwsT

http://sco.lt/9CtwsT


Pharma Exec Compensation in 2016

What a disgrace!

The chairman of a generics maker in hot water with the U.S. government and American parents—Mylan’sRobert Coury—would step off the company’s employee roster and into the nonexecutive chairman’s job and reap a $97 million package with the move

http://sco.lt/7dv0ID

http://sco.lt/7dv0ID


Pharma Commercial Support of CME

The pharmaceutical industry spent more on accredited continuing medical education in 2016 than it did in 2015, with spending hitting $704 million last year, up from $693 million in 2015 — a 1.5% increase.

[Note: If you include advertising and exhibit income -almost all of which is paid by pharma - then the year-over-year increase is more like 2.9%.]

In 2016, about one-quarter — 28% — of all CME investment came from the phama industry, according to an annual report from the Accreditation Council for Continuing Medical Education (ACCME).

http://sco.lt/6r0zqL

http://sco.lt/6r0zqL


Pharma Payments to HCPs Topped $8 Bn in 2016

All told, nearly 631,000 physicians and approximately 1,146 teaching hospitals received $8.18 billion in payments and ownership and investment interests in 2016, according to tallies compiled by the CMS.

http://sco.lt/7ohZiL

http://sco.lt/7ohZiL


Over Half of the DTC Ad Spend by

the Top 10 Advertised Drugs in 2016 was Made

by Pfizer

http://sco.lt/5HEoTp



Ads for “Breakthrough” Cancer Drugs Are “An Ocean of Hype,” Say Oncologists

http://sco.lt/6Ru7mL

http://sco.lt/6Ru7mL


Direct-to-Consumer Advertising (DTCA) Is Effective In Increasing

Inappropriate Prescribing, Say Researchers




Will It Be Downhill from Here for DTC Spending?

According to data from Nielsen, the U.S. drug industry spent $5.6 billion on DTC ads, excluding digital ads (read “Direct-to-Consumer #Pharma Drug Ad Spending at an All-Time High”; http://sco.lt/61NlRpAccording to the Nielsen chart shown here, the 2016 spend may have been $5.8 billion (excluding digital but including cinema).

Related: Spending in and around much-heralded digital channels was more or less flat ($515 million in 2016 versus $516 million in 2015).

http://sco.lt/5IZeSn

http://sco.lt/61NlRp

http://sco.lt/5IZeSn


Form 2253 Data Show Increase in Internet Drug Ads

From 2011–2014 (the years during which Internet promotion submissions were separated by audience) Internet promotion was the single largest category of FDA Form 2253 submissions for both consumer and healthcare professionals.


Americans Consume More Opioids Per Person Than Any

Other Country America has about 4 percent of the world’s population — but about 27 percent of the world’s drug overdose deaths.

But recently, America has gotten much worse due to its massive opioid epidemic. In 1999, fewer than 17,000 people died from drug overdoses. In 2015, that grew to more than 52,000.

This is, for now, largely an American problem. After pharmaceutical companies heavily marketed their opioids in the US, and doctors followed through with massive numbers of prescriptions, America became the world’s leader in consuming opioids.

http://sco.lt/6G3xbd

http://sco.lt/6G3xbd


Wishing You a Happy New Year!

the year 2017 in charts

Health & Medicine